© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
NLS Pharmaceutics AG (NLSP) stock surged +10.80%, trading at $0.15 on NASDAQ, up from the previous close of $0.14. The stock opened at $0.15, fluctuating between $0.14 and $0.17 in the recent session.
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.
Employees | 6 |
Beta | -0.567 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
NLS Pharmaceutics AG (NASDAQ: NLSP) stock price is $0.15 in the last trading session. During the trading session, NLSP stock reached the peak price of $0.17 while $0.14 was the lowest point it dropped to. The percentage change in NLSP stock occurred in the recent session was 10.8% while the dollar amount for the price change in NLSP stock was $0.01.
The NASDAQ listed NLSP is part of Biotechnology industry that operates in the broader Healthcare sector. NLS Pharmaceutics AG designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Christian C. Wenger Dr. iur., L.L.M., LL.M., Ph.D.
Gen. Counsel
Mr. Chad C. Hellmann M.B.A.
Chief Financial Officer
Ms. Sharon Keys
Head of Regulatory Affairs
Mr. Keith Harrison Dewedoff
Chief Financial Officer
Mr. Eric Konofal M.D., Ph.D.
Chief Scientific Officer
Mr. Alexander Zwyer M.B.A.
Pres, Chief Executive Officer & Director
Dr. George Apostol M.D.
Chief Medical Officer and Global Head of R&D
NLSP's closing price is 23.33% higher than its 52-week low of $0.11 where as its distance from 52-week high of $1.02 is -86.51%.
Number of NLSP employees currently stands at 6.
Official Website of NLSP is: https://nlspharma.com
NLSP could be contacted at phone 414 451 22150 and can also be accessed through its website. NLSP operates from The Circle 6, Zurich, 8058, Switzerland.
NLSP stock volume for the day was 3.98M shares. The average number of NLSP shares traded daily for last 3 months was 5.87M.
The market value of NLSP currently stands at $7.05M with its latest stock price at $0.15 and 46.66M of its shares outstanding.